Brand Finance：2025年度全球医疗品牌价值及品牌强度评估报告（英文版）

The pharmaceutical industry has remained relatively stable over the past year, with the collective brand value of the world’s top 25 most valuable pharma brands rising marginally by 1% in 2025. The US is the nation with the largest contribution, home to 10 of the top 25 brands, accounting for almost half of the total brand value. Consolidation through mergers and acquisitions continues to shape the sector, underscored by past deals such as Amgen’s acquisition of Horizon Therapeutics and Lilly